Lindbrook Capital’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$4.79M Sell
28,861
-4,460
-13% -$698K 0.44% 33
2024
Q4
$4.82M Sell
33,321
-3,281
-9% -$508K 0.43% 37
2024
Q3
$5.93M Sell
36,602
-1,364
-4% -$217K 0.53% 31
2024
Q2
$5.55M Sell
37,966
-9,228
-20% -$1.37M 0.52% 32
2024
Q1
$7.47M Buy
47,194
+812
+2% +$129K 0.7% 24
2023
Q4
$7.27M Sell
46,382
-2,361
-5% -$362K 0.73% 23
2023
Q3
$7.59M Sell
48,743
-693
-1% -$114K 0.85% 19
2023
Q2
$8.18M Buy
49,436
+1,938
+4% +$313K 0.87% 17
2023
Q1
$7.36M Sell
47,498
-855
-2% -$138K 0.86% 17
2022
Q4
$8.54M Buy
48,353
+27,859
+136% +$4.81M 1.05% 13
2022
Q3
$3.35M Sell
20,494
-308
-1% -$52.1K 0.56% 24
2022
Q2
$3.69M Buy
20,802
+2,909
+16% +$518K 0.61% 22
2022
Q1
$3.17M Buy
17,893
+1,438
+9% +$245K 0.49% 28
2021
Q4
$2.81M Buy
16,455
+12,209
+288% +$2M 0.43% 31
2021
Q3
$686K Sell
4,246
-895
-17% -$153K 0.18% 46
2021
Q2
$847K Buy
5,141
+13
+0.3% +$2.15K 0.19% 42
2021
Q1
$843K Buy
5,128
+979
+24% +$158K 0.19% 44
2020
Q4
$653K Buy
4,149
+208
+5% +$30.7K 0.16% 49
2020
Q3
$587K Sell
3,941
-328
-8% -$48.5K 0.16% 49
2020
Q2
$600K Buy
4,269
+250
+6% +$36.4K 0.18% 45
2020
Q1
$527K Sell
4,019
-1,274
-24% -$181K 0.2% 42
2019
Q4
$772K Buy
5,293
+6
+0.1% +$814 0.27% 34
2019
Q3
$684K Sell
5,287
-117
-2% -$15.4K 0.26% 36
2019
Q2
$752K Buy
5,404
+685
+15% +$94.8K 0.29% 30
2019
Q1
$659K Hold
4,719
0.26% 38
2018
Q4
$608K Buy
+4,719
New +$658K 0.3% 33

Other funds holding JNJ

Lindbrook Capital's JNJ Position: Q1 2025 in Review

Lindbrook Capital reduced its Johnson & Johnson (JNJ) stake by 13% in Q1 2025, selling an estimated $698K and leaving 28,861 shares worth $4.79M. The position accounts for 0.44% of the portfolio, ranked #33.

Lindbrook Capital first reported a position in JNJ in Q4 2018 and has held it in 26 quarters since. The position peaked at $8.54M in Q4 2022. 4,148 funds tracked by Wall St. Rank hold JNJ as of Q1 2025.

  • Lindbrook Capital held 28,861 shares of Johnson & Johnson worth $4.79M as of Q1 2025.
  • Lindbrook Capital sold 4,460 Johnson & Johnson shares in Q1 2025, an estimated $698K.
  • Johnson & Johnson made up 0.44% of Lindbrook Capital's portfolio in Q1 2025, its #33 holding.
  • Lindbrook Capital first reported a position in Johnson & Johnson in Q4 2018 and has held it in 26 quarters since.
  • Lindbrook Capital's Johnson & Johnson position peaked at $8.54M in Q4 2022.
  • 4,148 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.